Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction

NCT02027454 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG: GSK1265744
DRUG: GSK1265744 matching placebo
DRUG: Moxifloxacin

Sponsor

ViiV Healthcare

Collaborators

[object Object]